Nuklearmedizin 2004; 43(03): 69-71
DOI: 10.1055/s-0038-1625598
Editorial
Schattauer GmbH

Subclinical thyroid disease

Subklinische Schilddrüsenerkrankung
Further Information

Publication History





Publication Date:
10 January 2018 (online)

 

 
  • Literatur

  • 1 Andersen S, Pedersen KM, Bruun NH. et al. Narrow individual variations in serum T4 and T3 in normal subjects: A clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068-72.
  • 2 Col NF, Surks MI, Daniels GH. Subclinical thyroid disease – clinical applications. JAMA 2004; 291: 239-43.
  • 3 Dietlein M, Dressler J, Grünwald F. et al. Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2). Nuklearmedizin 2003; 42: 109-15.
  • 4 Dietlein M, Moka D, Schmidt M. et al. Prevention, screening and therapy of thyroid diseases and their cost-effectiveness. Nuklearmedizin 2003; 42: 181-9.
  • 5 Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: A summary of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med 2004; 140: 128-41.
  • 6 Kreuzberg U, Theissen P, Schicha H. et al. Single-channel activity and expression of atrial L-type Ca2+ channels in patients with latent hyperthyroidism. Am J Physiol Heart Circ Physiol 2000; 278: H723-30.
  • 7 Sharp D. Whose normal thyroid function is better – yours or mine?. Lancet 2002; 360: 353-4.
  • 8 Spencer CA. Subclinical hypothyroidism and TSH – new aspects on TSH reference values. Guest Lecture anlässlich der Tagung Schilddrüse Heidelberg 2003; Berlin: De Gruyter; 2004
  • 9 Surks MI, Ortiz E, Daniels GH. et al. Subclinical thyroid disease – scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38.